dense breast, breast density, FDA policy, nationwide law

August 1, 2013 — The U.S. Food and Drug Administration (FDA) has added consideration of a regulatory amendment to address breast density reporting could mean standardized nationwide notification in the "lay" letter women receive after their mammograms.

A Breast Density Reporting amendment to the Mammography Quality Standards Act (MQSA) is scheduled as a notice of proposed rulemaking in December 2013.  According to the abstract, the "FDA is proposing to amend its regulations governing mammography. The amendments would update the regulations issued under the Mammography Quality Standards Act of 1992 (MQSA). FDA is taking this action to address changes in mammography technology and mammography processes, such as breast density reporting, that have occurred since the regulations were published in 1997."  

Currently, 12 states have enacted breast density inform laws. It is estimated about 40 percent of American women live in states with mandatory notification. The 12 individually authored laws yield inconsistent state-to-state density notification. Breast density inform grassroots advocates have sought a single standard through federal regulation or legislation.  

"I'm pleased that the FDA is committed to notifying women about their breast density which will enable earlier stage diagnoses and more favorable outcomes,” said Rep. Steve Israel (N.Y.), cosponsor of The Breast Density and Mammography Reporting Act. “While I will continue my work in Congress to get the Breast Density and Mammography Reporting Act passed to require these notifications, it’s crucial that we pursue every option available to require that women receive access to this life-saving information."  The Act, sponsored by Rep. Rosa DeLauro (CT), will be re-introduced in 2013.

"MQSA regulatory amendment progress is welcomed news. To date, state-by-state mandatory breast density inform laws have been championed by cancer fighters and survivors who learned of the inherent risks of their dense tissue after their diagnosis," said JoAnn Pushkin, DENSE NY (Density Education National Survivors' Effort) founder, whose efforts led to the regulatory amendment consideration.  "Inspired by the nation's first Breast Density Inform law enacted in Connecticut in 2009, advocates from coast to coast have pursued state density inform legislation. For those patient/advocates fighting for breast density inform laws, an MQSA amendment to require patient density notification would mean one less battle waged by these champions who will now have time to focus on their own health. Nationwide breast density notification is one step closer to becoming a reality."


Related Content

News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | RSNA 2025

Nov. 3, 2025 — QT Imaging Holdings has announced that its chief medical officer, Elaine luanow, MD, will host a seminar ...

Time November 04, 2025
arrow
Subscribe Now